Title
Oral Nipah Vaccine

CoPED ID
62af5057-142d-4970-8d74-e4c959063acc

Status
Active

Funder

Value
£288,608

Start Date
March 31, 2022

End Date
March 30, 2023

Description

More Like This


IosBio has developed a technology which enables the generation of thermally stable, orally administered vaccines. We will utilise this technology to develop a candidate Nipah vaccine, a disease identified as having pandemic potential.

Iosbio Ltd LEAD_ORG
Iosbio Ltd PARTICIPANT_ORG

Andrew BACON PM_PER

Subjects by relevance
  1. Vaccines
  2. Pandemics
  3. Technological development
  4. Technology
  5. Diseases
  6. Vaccination
  7. History
  8. Communicable diseases

Extracted key phrases
  1. Candidate Nipah vaccine
  2. Oral Nipah Vaccine
  3. Technology
  4. Generation
  5. IosBio
  6. Stable
  7. Disease
  8. Pandemic potential

Related Pages

UKRI project entry

UK Project Locations